Kuwait’s pharmaceutical regulator on Monday granted emergency use approval for an artificial antibody-drug known as ‘Ronapreve’ to treat COVID19, the health ministry said.
The antibody-drug, developed by the US biotech company Regeneron, has been approved by the Medicines and Healthcare products Regulatory Agency; UK’s drug regulator, said the ministry’s Assistant Undersecretary for drug control Dr. Abdullah Al-Bader.
The drug is effective in reducing the likelihood of COVID-induced hospitalizations, added the official, hailing the medication as a useful tool to ease the strain on hospitals.
Source- KUNA
Read Today's News TODAY... on our Telegram Channel click here to join and receive all the latest updates t.me/thetimeskuwait
